Longevity & AgingBlood histidine levels track with immunotherapy success across 16 cancer cohorts
Immune-checkpoint inhibitors help only some patients with advanced cancer. Researchers profiled 154 plasma metabolites in 4,336 samples from 1,714 patients across 16 cohorts and five tumor types. A machine-learning model combined metabolites with clinical data to predict 12-month progression-free survival. Histidine, an essential amino acid from dietary protein, was the strongest favorable marker. Succinate and long-chain fatty acids were linked to worse outcomes. Higher histidine also tracked with longer survival in several external cohorts and with lower cancer risk in smokers with cardiovascular disease. In mice, oral histidine tended to enhance checkpoint-inhibitor effects and slowed tumor establishment. Per the abstract, histidine-rich diets improved survival in patients without microbiome signatures of histidine breakdown. The findings are associative and need prospective testing before anyone changes diet or treatment.